Sia D, Villanueva A, Friedman SL, Llovet JM (2017) Liver cancer cell of origin, molecular class, and effects on patient prognosis. Gastroenterology 152:745–761

Article  CAS  PubMed  Google Scholar 

Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59:776–779

Article  PubMed  Google Scholar 

Tanaka Y, Inoue T, Horie H (2013) International pediatric liver cancer pathological classification: current trend. Int J Clin Oncol 18:946–954

Article  PubMed  Google Scholar 

Pereira EM, Marion R, Ramesh KH, Kim JS, Ewart M, Ricafort R (2012) Hepatoblastoma in a Mosaic Trisomy 18 Patient. J Pediatr Hematol Oncol 34:E145–E148

Article  PubMed  Google Scholar 

Trobaugh-Lotrario AD, Lopez-Terrada D, Li P, Feusner JH (2018) Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: clinical characteristics and rationale for surveillance screening. Pediatr Blood Cancer 65:7

Article  Google Scholar 

Hamada Y, Takada K, Fukunaga S, Hioki K (2003) Hepatoblastoma associated with Beckwith-Wiedemann syndrome and hemihypertrophy. Pediatr Surg Int 19:112–114

Article  CAS  PubMed  Google Scholar 

Blaker H, Hofmann WJ, Rieker RJ, Penzel R, Graf M (1999) Otto, beta-catenin accumulation and mutation of the CTNNBI gene in hepatoblastoma. Gene Chromosomes Cancer 25:399–402

Article  CAS  Google Scholar 

Zhang Y, Solinas A, Cairo S, Evert M, Chen X, Calvisi DF (2021) Molecular mechanisms of hepatoblastoma. Semin Liver Dis 41:28–41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, Mistretta TA, Margolin J, Finegold MJ (2009) Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK plus precursors. Hum Pathol 40:783–794

Article  CAS  PubMed  Google Scholar 

Kinoshita Y, Tanaka S, Souzaki R, Miyoshi K, Kohashi K, Oda Y, Nakatsura T, Taguchi T (2015) Glypican 3 expression in pediatric malignant solid tumors. Eur J Pediatr Surg 25:138–143

PubMed  Google Scholar 

Feng TC, Zai HY, Jiang W, Zhu Q, Jiang B, Yao L, Li XY, Wang ZM (2019) Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database. Ann Transl Med 7:12

Article  Google Scholar 

Ng K, Mogul DB (2018) Pediatric Liver Tumors. Clin Liver Dis 22:753

Article  PubMed  Google Scholar 

Cheng C, He T, Chen K, Cai Y, Gu Y, Pan L, Duan P, Wu Y, Wu Z (2023) P300 interacted with N-Myc and regulated its protein stability via altering its post-translational modifications in neuroblastoma. Mol Cell Proteomics 22:100504

Article  CAS  PubMed  PubMed Central  Google Scholar 

Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550

Article  PubMed  PubMed Central  Google Scholar 

Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021) clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. The Innovation 2:100141

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carrillo-Reixach J, Torrens L, Simon-Coma M, Royo L, Domingo-Sabat M, Abril-Fornaguera J, Akers N, Sala M, Ragull S, Arnal M, Villalmanzo N, Cairo S, Villanueva A, Kappler R, Garrido M, Guerra L, Sabado C, Guillen G, Mallo M, Pineyro D, Vazquez-Vitali M, Kuchuk O, Mateos ME, Ramirez G, Santamaria ML, Mozo Y, Soriano A, Grotzer M, Branchereau S, de Andoin NG, Lopez-Ibor B, Lopez-Almaraz R, Salinas JA, Torres B, Hernandez F, Uriz JJ, Fabre M, Blanco J, Paris C, Bajciova V, Laureys G, Masnou H, Clos A, Belendez C, Guettier C, Sumoy L, Planas R, Jorda M, Nonell L, Czauderna P, Morland B, Sia D, Losic B, Buendia MA, Sarrias MR, Llovet JM, Armengol C (2020) Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications. J Hepatol 73:328–341

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hashemi M, Rashidi M, Hushmandi K, Ten Hagen TLM, Salimimoghadam S, Taheriazam A, Entezari M, Falahati M (2023) HMGA2 regulation by miRNAs in cancer: affecting cancer hallmarks and therapy response. Pharmacol Res 190:106732

Article  CAS  PubMed  Google Scholar 

Park DJ, Sung PS, Kim JH, Lee GW, Jang JW, Jung ES, Bae SH, Choi JY, Yoon SK (2020) EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer. https://doi.org/10.1136/jitc-2019-000301

Article  PubMed  PubMed Central  Google Scholar 

Hsieh MH, Wei Y, Li L, Nguyen LH, Lin YH, Yong JM, Sun X, Wang X, Luo X, Knutson SK, Bracken C, Daley GQ, Powers JT, Zhu H (2024) Liver cancer initiation requires translational activation by an oncofetal regulon involving LIN28 proteins. J Clin Invest 134

Rong D, Wu F, Lu C, Sun G, Shi X, Chen X, Dai Y, Zhong W, Hao X, Zhou J, Xia Y, Tang W, Wang X (2021) M6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression. Mol Ther Nucleic Acids 26:637–648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu G, Wang N, Zhang C, Li M, He X, Yin C, Tu Q, Shen X, Zhang L, Lv J, Wang Y, Jiang H, Chen S, Li N, Tao Y, Yin H (2021) Fructose-1,6-bisphosphate aldolase B depletion promotes hepatocellular carcinogenesis through activating insulin receptor signaling and lipogenesis. Hepatology 74:3037–3055

Article  CAS  PubMed  Google Scholar 

Wu J, Dan C, Zhao HB, Xiao CX, Liu YP, Si LJ, Ren JL, Guleng B (2014) Aldob acts as a novel HBsAg-binding protein and its coexistence inhibits cisplatin-induced HepG2 cell apoptosis. Crit Rev Eukaryot Gene Expr 24:181–191

Article  CAS  PubMed  Google Scholar 

Leong I (2018) Aldob promotes liver metastases development. Nat Rev Endocrinol 14:380

Article  CAS  PubMed  Google Scholar 

Huangyang P, Li F, Lee P, Nissim I, Weljie AM, Mancuso A, Li B, Keith B, Yoon SS, Simon MC (2020) Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab 31:174–188e177

Article  CAS  PubMed  Google Scholar 

Wang L, Wang J, Shen Y, Zheng Z, Sun J (2022) Fructose-1,6-bisphosphatase 2 inhibits oral squamous cell carcinoma tumorigenesis and glucose metabolism via downregulation of c-Myc. Oxid Med Cell Longev 2022:6766787

Article  PubMed  PubMed Central  Google Scholar 

Wang YC, Li J, Guo SX, Ouyang YS, Yin LY, Liu SS, Zhao ZP, Yang JL, Huang WJ, Qin H, Zhao X, Ni B, Wang HZ (2017) Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma. Oncotarget 8:60414–60428

Article  PubMed  PubMed Central  Google Scholar 

Wu TF, Jia J, Xiong XP, He HJ, Bu LL, Zhao ZL, Huang CF, Zhang WF (2013) Increased expression of Lin28B associates with poor prognosis in patients with oral squamous cell carcinoma. PLoS One 8:9

Article  Google Scholar 

Kugel S, Sebastian C, Fitamant J, Ross KN, Saha SK, Jain E, Gladden A, Arora KS, Kato Y, Rivera MN, Ramaswamy S, Sadreyev RI, Goren A, Deshpande V, Bardeesy N, Mostoslavsky R (2016) SIRT6 suppresses pancreatic cancer through control of Lin28b. Cell 165:1401–1415

Article  CAS  PubMed  PubMed Central  Google Scholar 

King CE, Wang L, Winograd R, Madison BB, Mongroo PS, Johnstone CN, Rustgi AK (2011) LIN28B fosters colon cancer migration, invasion and transformation through let-7-dependent and -independent mechanisms. Oncogene 30:4185–4193

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balzeau J, Menezes MR, Cao SY, Hagan JP (2017) The LIN28/let-7 pathway in cancer. Front Genet 8:1–16

Article  Google Scholar 

Wang TZ, Wang GY, Hao DP, Liu X, Wang D, Ning N, Li XB (2015) Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer. Mol Cancer. https://doi.org/10.1186/s12943-015-0402-5

Article  PubMed  PubMed Central